MedKoo Cat#: 562835 | Name: VPC-14228
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

VPC-14228 is a specific inhibitor of AR-DBD. It acts by inhibiting both Y594A and Q592A mutants, blocking the interaction of the AR with androgen response elements in the nucleus..

Chemical Structure

VPC-14228
VPC-14228
CAS#19983-28-9

Theoretical Analysis

MedKoo Cat#: 562835

Name: VPC-14228

CAS#: 19983-28-9

Chemical Formula: C13H14N2OS

Exact Mass: 246.0827

Molecular Weight: 246.32

Elemental Analysis: C, 63.39; H, 5.73; N, 11.37; O, 6.49; S, 13.02

Price and Availability

Size Price Availability Quantity
5mg USD 540.00
25mg USD 620.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
VPC-14228; VPC 14228; VPC14228;
IUPAC/Chemical Name
4-(4-Phenylthiazol-2-yl)morpholine
InChi Key
MRNNJVNMXOZEQC-UHFFFAOYSA-N
InChi Code
InChI=1S/C13H14N2OS/c1-2-4-11(5-3-1)12-10-17-13(14-12)15-6-8-16-9-7-15/h1-5,10H,6-9H2
SMILES Code
N1(C2=NC(C3=CC=CC=C3)=CS2)CCOCC1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Certificate of Analysis
Safety Data Sheet (SDS)

Preparing Stock Solutions

The following data is based on the product molecular weight 246.32 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Pang, J. P., Shen, C., Zhou, W. F., Wang, Y. X., Shan, L. H., Chai, X., ... & Hou, T. J. (2022). Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays. Acta Pharmacologica Sinica, 43(1), 229-239. Dehm, S., Rennie, P., Gewirth, D., & University of Minnesota Minneapolis United States. (2015). Development of a New Class of Drugs to Inhibit All Forms of Androgen Receptor in Castration Resistant Prostate Cancers. Bhumireddy, A., Bandaru, N. R., Reddy, B. R., Gore, S. T., Mukherjee, S., Balasubramanian, W. R., ... & Samajdar, S. (2022). Design, synthesis, and biological evaluation of phenyl thiazole-based AR-V7 degraders. Bioorganic & medicinal chemistry letters, 55, 128448.